Skip to search
Skip to main content
Back to Search
Start Over
First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: an open-label multicentre randomised controlled trial
Authors :
MDL Child Health Jongsma, Maria M E Aardoom, Martine A Cozijnsen, Martinus A van Pieterson, Merel de Meij, Tim Groeneweg, Michael Norbruis, Obbe F Wolters, Victorien M van Wering, Herbert M Hojsak, Iva Kolho, Kaija-Leena Hummel, Thalia Stapelbroek, Janneke van der Feen, Cathelijne van Rheenen, Patrick F van Wijk, Michiel P Teklenburg-Roord, Sarah T A Schreurs, Marco W J Rizopoulos, Dimitris Doukas, Michail Escher, Johanna C Samsom, Janneke N de Ridder, Lissy MDL Child Health Jongsma, Maria M E Aardoom, Martine A Cozijnsen, Martinus A van Pieterson, Merel de Meij, Tim Groeneweg, Michael Norbruis, Obbe F Wolters, Victorien M van Wering, Herbert M Hojsak, Iva Kolho, Kaija-Leena Hummel, Thalia Stapelbroek, Janneke van der Feen, Cathelijne van Rheenen, Patrick F van Wijk, Michiel P Teklenburg-Roord, Sarah T A Schreurs, Marco W J Rizopoulos, Dimitris Doukas, Michail Escher, Johanna C Samsom, Janneke N de Ridder, Lissy
Publication Year :
2020
Details
Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1432114721
Document Type :
Electronic Resource